CVRdatabase
Menu

Nordic microbes A/S

Public limited companyCVR 42559997Odense CActive

Nordic microbes A/S is a public limited company, based in Odense C, active in research and experimental development on natural sciences and engineering, founded in 2021. The company made a loss in both 2024 and 2025, most recently DKK 11.3m. With 20 employees, the company is about 4 times larger than the industry median. Equity grew to DKK 66.3m in 2025.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profitDKK 4.9m−20.4% vs. 2024
Net profit−DKK 11.3m−73.5% vs. 2024
EquityDKK 66.3m+50.1% vs. 2024
Employees20latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit fell 20% (2024 → 2025), to DKK 4.9m.
  • The loss grew: from DKK 6.5m to DKK 11.3m (2024 → 2025).
  • Equity rose 50% (2024 → 2025), to DKK 66.3m.

Employees

  • 1 fewer employees than a year earlier: 20 (07/2026) against 21 (07/2025).

Management and owners, last 24 months

  • New in management: Thomas Hessellund (chair of the board, 17/12/2024), Niels Dengsø Jensen (board member, 02/12/2025) and Christopher Jeremy Horne (board member, 25/02/2026) (+2).
  • Stepped down: Henrik Busch-Larsen (chair of the board, 16/12/2024), Anders Kjær (board member, 02/12/2025) and Morten Østergaard Andersen (board member, 02/12/2025) (+2).
  • New owners registered: Aurelius Limited (19/12/2024).

Registrations, last 24 months

  • 16/06/2026: Share capital changed from 481,849 DKK to 484,226 DKK
  • 17/09/2025: Share capital changed from 459,784 DKK to 481,849 DKK
  • 22/07/2025: Share capital changed from 402,520 DKK to 459,784 DKK
  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2022–2025 · amounts in DKK thousand

Equity and net profit

−DKK 20m−DKK 10mDKK 0DKK 10mDKK 20mDKK 30mDKK 40mDKK 50mDKK 60mDKK 70m2022202320242025
EquityNet profit
Financial figures for Nordic microbes A/S
2022202320242025Change
Revenuenot statednot statednot statednot stated–
Gross profit3,4244,5426,1484,895−20.4%
Operating profit (EBIT)−2,880−5,878−9,802−14,948−52.5%
Profit before tax−3,090−5,927−8,611−14,850−72.4%
Net profit−2,161−4,526−6,523−11,316−73.5%
Total assets13,08852,17246,06967,567+46.7%
Equity7,87750,68244,15966,299+50.1%
Liabilities5,2111,4901,6311,103−32.4%
Cash and cash equivalents2,79734,84612,35021,801+76.5%
Average number of employees7152022+10%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 1mDKK 2mDKK 3mDKK 4mDKK 5mDKK 6m2022202320242025
Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Loss for 4 years in a row

    Net result has been negative in 2022–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

4 financial years
Annual reports for Nordic microbes A/S
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202502/07/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202430/05/2025The companyPDFXBRL
202301/01/2023 – 31/12/202316/05/2024The companyPDFXBRL
202223/07/2021 – 31/12/202216/03/2023The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
051015202508/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profitDKK 4.9mNo. 117 of 421
Better than 72% of the companies in the industry
EquityDKK 66.3mNo. 53 of 431
Better than 88% of the companies in the industry
Number of employees20No. 87 of 431
Better than 80% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bnHere
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with 20–49 employees9,922 companies in the comparison
No. 7,748of 9,892
Better than 22%
No. 545of 9,922
Better than 95%
Same industry and 20–49 employees64 companies in the comparison
No. 35of 62
Better than 44%
No. 20of 64
Better than 70%
Companies that are between 5 and 14 years old33,688 companies in the comparison
No. 8,809of 33,588
Better than 74%
No. 965of 33,687
Better than 97%
All companies of type A/S18,025 companies in the comparison
No. 12,060of 17,786
Better than 32%
No. 2,994of 18,024
Better than 83%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. Nordic microbes A/SDKK 4.9m
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. Nordic microbes A/S−DKK 11.3m
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. Nordic microbes A/SDKK 66.3m
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. Nordic microbes A/S20
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Omixholding ApS33.33%
  • Planetary Impact Ventures Fund K/S5%
  • PSV Hafnium Fund I K/S5%
  • Aurelius Limited5%
Nordic microbes A/S

Management

5 active registrations

Executive management

Executive management at Nordic microbes A/S
NameRoleAppointed
Morten Østergaard AndersenDirector23/07/2021

Board of directors

Board of directors at Nordic microbes A/S
NameRoleAppointed
Anders Peter GramBoard member29/03/2023
Thomas HessellundChair of the board17/12/2024
Niels Dengsø JensenBoard member02/12/2025
Christopher Jeremy HorneBoard member25/02/2026
Founders
Omixholding ApS
Former management (6)
Former management at Nordic microbes A/S
NameRoleAppointedResigned
Henrik Busch-LarsenChair of the board11/04/202216/12/2024
Anders KjærBoard member11/04/202202/12/2025
Julia Magdalena Østergaard AndersenBoard member11/04/202208/05/2024
Morten Østergaard AndersenBoard member08/05/202402/12/2025
Thomas HessellundBoard member16/12/202416/12/2024
Henrik Busch-LarsenBoard member17/12/202425/02/2026

Signing rule: Selskabet tegnes af et medlem af bestyrelsen sammen med en direktør.

Address and production units

1 active production units

Kochsgade 25
5000 Odense C

Odense Municipality · Postcode 5000

Production units
Production unitAddressEmployeesP number
Nordic microbes A/SKochsgade 25, 5000 Odense C201027391032

Purpose

Selskabets formål er at udvikle og sælge bioteknologiske produkter.

The purpose is quoted from the register in Danish.

Changes year by year

50 registered events
20264 changesaccounts 1 · capital 1 · management 2
  • Annual report for 2025 published
  • Share capital changed from 481,849 DKK to 484,226 DKK
  • Christopher Jeremy Horne appointed board member
  • Henrik Busch-Larsen stepped down as board member
20257 changesmanagement 3 · capital 2 · accounts 1 · industry 1
  • Niels Dengsø Jensen appointed board member
  • Morten Østergaard Andersen stepped down as board member
  • Anders Kjær stepped down as board member
  • Share capital changed from 459,784 DKK to 481,849 DKK
  • Share capital changed from 402,520 DKK to 459,784 DKK
  • Annual report for 2024 published
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
202412 changesownership 3 · management 7 · name 1 · accounts 1
  • AURELIUS LIMITED registered as owner (5%)
  • Henrik Busch-Larsen appointed board member
  • Thomas Hessellund appointed chair of the board
  • Thomas Hessellund appointed board member
  • Thomas Hessellund stepped down as board member
  • Henrik Busch-Larsen stepped down as chair of the board
  • Name changed from Bioomix A/S to Nordic microbes A/S
  • PSV Hafnium Fund I K/S registered as owner (5%)
  • PreSeed Ventures A/S is no longer registered as owner
  • Annual report for 2023 published
  • Morten Østergaard Andersen appointed board member
  • Julia Magdalena Østergaard Andersen stepped down as board member
20239 changesname 1 · capital 1 · ownership 4 · address 1 · management 1 · accounts 1
  • Name changed from Bioomix ApS to Bioomix A/S
  • Share capital changed from 55,265 DKK to 402,520 DKK
  • Planetary Impact Ventures Fund K/S registered as owner (5%)
  • Omixholding ApS registered as owner (33.33%)
  • SCIENCE VENTURES DENMARK A/S is no longer registered as owner
  • Omixholding ApS is no longer registered as owner
  • Moved to Kochsgade 25, 5000 Odense C
  • Anders Peter Gram appointed board member
  • Annual report for 2022 published
202214 changesaddress 2 · capital 1 · management 3 · ownership 8
  • Moved to Kochsgade 25, 5000 Odense C
  • Moved to Kochsgade 23, 5000 Odense C
  • Share capital changed from 40,000 DKK to 55,265 DKK
  • Anders Kjær appointed board member
  • Julia Magdalena Østergaard Andersen appointed board member
  • Henrik Busch-Larsen appointed chair of the board
  • Omixholding ApS registered as owner (50%)
  • PreSeed Ventures A/S registered as owner (5%)
  • SCIENCE VENTURES DENMARK A/S registered as owner (5%)
  • Omixholding ApS is no longer registered as owner
  • SCIENCE VENTURES DENMARK A/S is no longer registered as owner
  • Omixholding ApS registered as owner (90%)
  • SCIENCE VENTURES DENMARK A/S registered as owner (10%)
  • Omixholding ApS is no longer registered as owner
20214 changesaddress 1 · founded 1 · management 1 · ownership 1
  • Moved to Buchwaldsgade 15, 1. tv, 5000 Odense C
  • Registered as Bioomix ApS
  • Morten Østergaard Andersen appointed director
  • Omixholding ApS registered as owner (100%)

Related companies

Same industry in Odense

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.

View in CVRReport a correction